| 1 |
31574962 | Synthesis, Biological Activities and Docking Studies of Novel 4-(Arylaminomethyl)benzamide Derivatives as Potential Tyrosine Kinase Inhibitors. | 2019 Sep 30 |
1 |
| 2 |
22314840 | Metabolism of peptide reporters in cell lysates and single cells. | 2012 Jul 7 |
1 |
| 3 |
19557636 | New mutations detected by denaturing high performance liquid chromatography during screening of exon 6 bcr-abl mutations in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. | 2009 Jul |
1 |
| 4 |
17382017 | Emerging strategies for the treatment of mutant Bcr-Abl T315I myeloid leukemia. | 2007 Mar |
1 |
| 5 |
17804707 | Crystal structure of the T315I Abl mutant in complex with the aurora kinases inhibitor PHA-739358. | 2007 Sep 1 |
1 |
| 6 |
17164333 | Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants. | 2006 Dec 19 |
1 |
| 7 |
12149456 | Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. | 2002 Aug 6 |
1 |